fbpx

Life+News The Official News Portal of Independent Television Network Ltd

Colombia regulator approves Pfizer-BioNTech vaccine for emergency use

ITN News Editor
By ITN News Editor January 7, 2021 17:48

Colombia regulator approves Pfizer-BioNTech vaccine for emergency use

Colombia’s food and drug regulator on Tuesday (January 5) authorised emergency use of Pfizer Inc and BioNTech SE’s COVID-19 vaccine, joining other countries that have already approved coronavirus vaccines.

The Pfizer-BioNTech vaccine, which has shown a 95% success rate, was formally approved by the National Institute of Food and Drug Surveillance (Invima).

The country now awaits approval for vaccines produced by AstraZeneca and Johnson & Johnson’s pharmaceutical unit Janssen.

Patients aged 60 and over, or with conditions like asthma and diabetes, will be among the first in line for vaccines, as well as health workers.

Colombia has agreed to buy 10 million doses each of the Pfizer-BioNTech and AstraZeneca vaccines, as well as nine million from Janssen. The country has also secured 20 million vaccine doses via the World Health Organisation-backed COVAX mechanism.

Colombia will receive its first delivery of 1.7 million Pfizer-BioNTech vaccine doses in February, with vaccinations beginning immediately, according to the minister of health.

Colombia, which has reported 1.7 million coronavirus infections and 44,426 deaths, aims to vaccinate 35.7 million of its 50 million inhabitants.

ITN News Editor
By ITN News Editor January 7, 2021 17:48

BUSINESS NEWS- VIEW ALL

SPORTS NEWS- VIEW ALL

ENTERTAINMENT- VIEW ALL